ATE287699T1 - Pharmazeutische aerosolzusammensetzungen - Google Patents

Pharmazeutische aerosolzusammensetzungen

Info

Publication number
ATE287699T1
ATE287699T1 AT98955755T AT98955755T ATE287699T1 AT E287699 T1 ATE287699 T1 AT E287699T1 AT 98955755 T AT98955755 T AT 98955755T AT 98955755 T AT98955755 T AT 98955755T AT E287699 T1 ATE287699 T1 AT E287699T1
Authority
AT
Austria
Prior art keywords
drug
aerosol compositions
pharmaceutical aerosol
propellant
aerosol formulation
Prior art date
Application number
AT98955755T
Other languages
English (en)
Inventor
Yvonne Mary Beatrice Pritchard
Chapel Lane Row
Kanwaljit Singh Claire
Original Assignee
Minnesota Mining & Mfg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining & Mfg filed Critical Minnesota Mining & Mfg
Application granted granted Critical
Publication of ATE287699T1 publication Critical patent/ATE287699T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT98955755T 1997-12-08 1998-11-20 Pharmazeutische aerosolzusammensetzungen ATE287699T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9725984A GB2332372B (en) 1997-12-08 1997-12-08 Pharmaceutical aerosol compositions
PCT/GB1998/003488 WO1999029296A1 (en) 1997-12-08 1998-11-20 Pharmaceutical aerosol compositions

Publications (1)

Publication Number Publication Date
ATE287699T1 true ATE287699T1 (de) 2005-02-15

Family

ID=10823304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98955755T ATE287699T1 (de) 1997-12-08 1998-11-20 Pharmazeutische aerosolzusammensetzungen

Country Status (11)

Country Link
EP (1) EP1037604B1 (de)
JP (1) JP5384776B2 (de)
AT (1) ATE287699T1 (de)
AU (1) AU759746B2 (de)
BR (1) BRPI9813397B8 (de)
CA (1) CA2311450C (de)
DE (1) DE69828817T2 (de)
ES (1) ES2234165T3 (de)
GB (1) GB2332372B (de)
PT (1) PT1037604E (de)
WO (1) WO1999029296A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9707864A (es) * 1995-04-14 1997-11-29 Glaxo Wellcome Inc Inhalador de dosis medida por salmeterol.
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6423298B2 (en) 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
FR2798290B1 (fr) * 1999-09-11 2003-09-12 Glaxo Group Ltd Formulation pharmaceutique de propionate de fluticasone
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
US20040191176A1 (en) * 2003-03-28 2004-09-30 Kaplan Leonard W Formulations for treatment of pulmonary disorders
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
EP2077132A1 (de) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Abgabevorrichtung, Aufbewahrungsvorrichtung und Verfahren zur Abgabe einer Formulierung
EP2414560B1 (de) 2009-03-31 2013-10-23 Boehringer Ingelheim International GmbH Verfahren zur beschichtung einer oberfläche eines bauteils
US9265910B2 (en) 2009-05-18 2016-02-23 Boehringer Ingelheim International Gmbh Adapter, inhalation device, and nebulizer
EP2504051B1 (de) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Zerstäuber
CA2781792C (en) 2009-11-25 2019-04-02 Boehringer Ingelheim International Gmbh Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
US20120272951A1 (en) * 2009-12-16 2012-11-01 3M Innovative Properties Company Formulations and methods for controlling mdi particle size delivery
EP2585151B1 (de) 2010-06-24 2018-04-04 Boehringer Ingelheim International GmbH Vernebler
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
JP6643231B2 (ja) 2013-08-09 2020-02-12 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
BR112016023983B1 (pt) 2014-05-07 2022-10-18 Boehringer Ingelheim International Gmbh Contentor para um nebulizador, nebulizador para um fluido e método para conectar um contentor a um dispositivo indicador
WO2015169430A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Nebulizer
SG11201608891RA (en) 2014-05-07 2016-11-29 Boehringer Ingelheim Int Nebulizer, indicator device and container
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US11452474B1 (en) 2021-04-14 2022-09-27 Satio, Inc. Dual lever dermal patch system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2769925B2 (ja) * 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
DE69205177T2 (de) * 1991-12-12 1996-03-21 Glaxo Group Ltd., Greenford, Middlesex Pharmazeutische Aerosolformulierung.
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
GB9425160D0 (en) * 1994-12-10 1995-02-08 Glaxo Group Ltd Medicaments
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
JP2003522102A (ja) * 1998-06-18 2003-07-22 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド ２種以上の活性物質を含むエアゾール用医薬製剤

Also Published As

Publication number Publication date
EP1037604B1 (de) 2005-01-26
EP1037604A1 (de) 2000-09-27
BRPI9813397B8 (pt) 2021-07-06
CA2311450A1 (en) 1999-06-17
AU759746B2 (en) 2003-05-01
BRPI9813397B1 (pt) 2011-08-23
WO1999029296A1 (en) 1999-06-17
GB2332372A (en) 1999-06-23
DE69828817T2 (de) 2006-05-18
CA2311450C (en) 2009-05-05
GB9725984D0 (en) 1998-02-04
DE69828817D1 (de) 2005-03-03
JP2001525354A (ja) 2001-12-11
JP5384776B2 (ja) 2014-01-08
BRPI9813397A (pt) 2000-10-10
ES2234165T3 (es) 2005-06-16
GB2332372B (en) 2002-08-14
PT1037604E (pt) 2005-05-31
AU1248699A (en) 1999-06-28

Similar Documents

Publication Publication Date Title
DE69828817D1 (de) Pharmazeutische aerosolzusammensetzungen
ATE291898T1 (de) Pharmazeutische aerosol formulierung enthaltend salmeterol und fluticason
ATE343374T1 (de) Fluticasonpropionat arzneizubereitung
YU59092A (sh) Formulacije aerosola koji ne sadrže hlorofluorougljenična jedinjenja
YU59192A (sh) Formulacija aerosola koje ne sadrže hlorofluorougljenična jedinjenja
GEP20053420B (en) Sustained Release Ranolanolazine Formulation
BR1100339A (pt) Formulações de aerossol em solução de beclometasona
DK1257254T3 (da) Formuleringer indeholdende et anticholinergt lægemiddel til behandling af kronisk obstruktiv lungesygdom
YU59899A (sh) Medicinski aerosolni proizvodi
NZ298169A (en) Aerosol drug formulation; comprises hydrofluoroalkane propellant, medicament for inhalation and a surfactant
DK1306082T3 (da) Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer
NO307864B1 (no) Farmasøytisk aerosolformulering, boks og doseringsinhalator
WO1995017156A3 (en) Ethanol substitutes
ATE180665T1 (de) Pharmazeutische zusammensetzungen und vorrichtungen zu deren verabreichung
NO305286B1 (no) Kinoksalinforbindelser, farmas°ytiske preparater som omfatter dem, og anvendelse derav for fremstilling av medikamenter
NO306993B1 (no) Piperidinylmetyloksyzolidin-2-on-derivater, farmasoeytiske preparater som inneholder slike, samt anvendelse av forbindelsene til fremstilling av legemidler
DE60007074D1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
DE50005282D1 (de) Medikament sowie aufeinander abgestimmte kombination von medikamenten
ATE286716T1 (de) Pharmazeutische formulierungen enthaltend salmeterol
MX9707238A (es) Formulaciones en aerosol de butixocort.
ITBA920007A0 (it) Formulazioni farmaceutiche per la somminstrazione sistemica per via nasale degli ormoni sessuali femminili naturali e di ormoni ad attivita' estrogenica e/o progestativa sia naturali che di sintesi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1037604

Country of ref document: EP